Moderna Therapeutics Overview

  • Founded
  • 2010
Founded
  • Status
  • Public
  • Employees
  • 2,700
Employees
  • Stock Symbol
  • MRNA
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $137.91
  • (As of Friday Closing)

Moderna Therapeutics General Information

Description

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 200 Technology Square
  • Cambridge, MA 02139
  • United States
+1 (617) 000-0000

Moderna Therapeutics Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Moderna Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$137.91 $130.17 $119.01 - $497.49 $54.9B 403M 7.37M $36.32

Moderna Therapeutics Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 59,613,262 94,653,071 38,275,827 5,493,633
Revenue 22,600,000 18,471,000 803,000 60,000
EBITDA 16,542,000 13,517,000 (728,000) (523,000)
Net Income 14,638,000 12,202,000 (747,000) (514,000)
Total Assets 27,609,000 24,669,000 7,337,000 1,589,422
Total Debt 947,000 916,000 237,000 132,364
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Moderna Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Moderna Therapeutics‘s full profile, request access.

Request a free trial

Moderna Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Moderna Therapeutics‘s full profile, request access.

Request a free trial

Moderna Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The
Drug Discovery
Cambridge, MA
2,700 As of 2021
00.00
00000000000 00.00

0000000

liquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillu
0000000000000
Gaithersburg, MD
0000 As of 0000
00000
000000000 00000

0000000

equat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla
0000 000000000
Cambridge, MA
000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Moderna Therapeutics Competitors (31)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novavax Corporation Gaithersburg, MD 0000 00000 000000000 00000
0000000 0000000000 Formerly VC-backed Cambridge, MA 000 00000 00000000 00000
0000000 Formerly VC-backed Tübingen, Germany 000 00.000 00000000 00.000
00000 000000000000 Corporate Backed or Acquired Carlsbad, CA 000 0000 00000000000 0000
00000000 Corporation Austin, TX 00 0000 00000000 0000
You’re viewing 5 of 31 competitors. Get the full list »

Moderna Therapeutics Patents

Moderna Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210228707-A1 Coronavirus rna vaccines Abandoned 28-Jan-2020 0000000000
US-20210217484-A1 Variational autoencoder for biological sequence generation Pending 10-Jan-2020 000000000
US-20210087135-A1 Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents Granted 19-Sep-2019 0000000000
US-11066355-B2 Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents Active 19-Sep-2019 0000000000 000
CA-3139321-A1 Polynucleotides for disrupting immune cell activity and methods of use thereof Pending 07-May-2019 C12N15/62
To view Moderna Therapeutics’s complete patent history, request access »

Moderna Therapeutics Executive Team (47)

Name Title Board Seat Contact Info
Stephane Bancel Chief Executive Officer & Board Member
Stephen Hoge MD President
David Meline Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Melanie Ivarsson Ph.D Senior Vice President & Chief Development Officer
Melissa Moore Ph.D Chief Scientific Officer
You’re viewing 5 of 47 executive team members. Get the full list »

Moderna Therapeutics Board Members (19)

Name Representing Role Since
Elizabeth Nabel MD Self Board Member 000 0000
Elizabeth Tallett Moderna Therapeutics Board Member 000 0000
Israel Ruiz Moderna Therapeutics Board Member 000 0000
Noubar Afeyan Ph.D Self Chairman & Board Member 000 0000
Paul Sagan Self Board Member 000 0000
You’re viewing 5 of 19 board members. Get the full list »

Moderna Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Moderna Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Moderna Therapeutics‘s full profile, request access.

Request a free trial

Moderna Therapeutics Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 22-Oct-2015 000000000 0000 Therapeutic Devices
0000000000 01-Jan-2015 000000000 00000 Biotechnology
Onkaido 14-Jan-2014 Corporate 0000 Drug Discovery
To view Moderna Therapeutics’s complete investments history, request access »

Moderna Therapeutics Subsidiaries (2)

Company Name Industry Location Founded
Valera Therapeutic Devices Cambridge, MA 2015
0000000 Drug Discovery Cambridge, MA 0000
To view Moderna Therapeutics’s complete subsidiaries history, request access »

Moderna Therapeutics Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 22-Oct-2015 000000000 0000 Completed
  • 0000000 0000000000
Onkaido 14-Jan-2014 Corporate 0000 Completed
To view Moderna Therapeutics’s complete exits history, request access »